You are here

SJF Pharmaceuticals

The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer

Sacramento Bee, CA

Sat, 09/8/12 - 11:28 am

non-small cell lung cancer

SJF Pharmaceuticals